what we do

Military Cardiovascular Outcomes Research (MiCOR) performs Randomized Clinical Trials (RCTs) in active duty personnel, retirees, and their dependents to determine the state of the art for treatment of conditions that give rise to cardiovascular illnesses including atherosclerosis, arrhythmias, and heart failure. The program emphasizes the identification of treatment approaches that are scalable and applicable to military cohorts located outside the tertiary care centers. MiCOR aims to define best practices to mitigate cardiovascular disease in the military in order to increase readiness, reduce health costs, and prevent cardiovascular morbidity later in life.

The program integrates a variety of subject matter expertise including cardiology, pharmacology, psychology and metabolic disorders while implementing cardiovascular prevention strategies in a variety of populations. MiCOR utilizes RCTs to test hypothesis-driven experiments in the specialized populations of military cohorts.

MiCOR uses the RCT platform to elucidate novel mechanisms of change, including, but not limited to autonomic nervous system, inflammatory measures, the microbiome and epigenetics. MiCOR primarily, but not exclusively, focuses on preventative approaches. While reducing cardiovascular risk is our primary outcome of this endeavor, preventing closely associated health comorbidities that disparately affect the military family, including obesity and eating disorders, is our secondary goal.



Mark Haigney  Director

M. Alaric Franzos Clinical Director 

Jason Lavender Assistant Research Director

Lead Program Staff: 

Autumn Mains Program Manager 

Tom Arnold, Lead Data Scientist -

Bethelhem Markos, MSc, RRT

Recent News: 

Watch: February 2023 Interview with NBC Now 

Marc Alaric Franzos MD, MPH, FACC, FACP of our MICOR Division was featured in the Journal of the American College of Cardiology in an article titledNavy Shipboard Medicine: Helping Humanity and Preparing For Future Wars